Replies to post #130 on MOST EXPLOSIVE

[DDGUY]

WHY a merger with CBAI is possible

NOW THE BIG ?

= if a company has more than $3billion whats the fastest way to grow (financially/client base)

Merger / BUYOUT of other companies, basically monopolize the market

One Possibility

I feel CBAI CORD BLOOD AMERICA is getting the financials together to be an attractive candidate, not only for shareholders but for a merger/buyout. not to forget the only publicly traded Cord Blood company.

Some people might say why now

1st: In October 2012 $3.25 billion of committed capital to CBR a competitor http://www.cordblood.com/about-cbr/stem-cell-research-news/press/2012/GTCR-Announces-Investment-in-Cord-Blood-Registry

2nd NEW CEO Geoff Crouse joined CBR as CEO in September 2012. He previously served as Chief Operating Officer at Immucor, a publicly traded.

3rd NEW CEO of CBAI http://www.linkedin.com/pub/joseph-vicente/9/90/93a Joseph Vicente Primarily involved in Mergers & Acquisitions, Corporate Governance

Will the benefits for CBR would be (going public, increase sales/client, chance to uplist NYSE/NASDAQ after the merger)


the company is still undervalued, but most know when financials are getting attractive, it normally means merger/buyout